Cytosorbents Corp

NASDAQ:CTSO   3:59:52 PM EDT
7.37
-0.03 (-0.40%)
Products

Cytosorbents Receives Full FDA Approval Of Investigational Device Exemption For U.S. Star-T Trial On Ticagrelor Removal During Cardiothoracic Surgery

Published: 07/06/2021 11:33 GMT
Cytosorbents Corp (CTSO) - Cytosorbents Receives Full FDA Approval of Investigational Device Exemption (ide) for U.S. Star-t Trial on Ticagrelor Removal During Cardiothoracic Surgery.
Cytosorbents Corp - Star-t Will Enroll Up to 120 Patients Across 20 U.S. Clinical Sites and is Expected to Begin Enrollment This Summer.